2022 House Bill 5969

Create a government opioid commission

Introduced in the House

March 24, 2022

Introduced by Rep. Mary Whiteford (R-80)

To create a 24-member “opioid advisory commission” within the Legislative Council, a bipartisan entity that administers the legislative branch of state government. This would be comprised of specified political appointees and state officials, and would provide annual reviews of state government’s activities in this area. This would be in addition to a separate “Prescription Drug and Opioid Abuse Commission” in the Department of Licensing and Regulatory Affairs, which itself replaced an earlier Controlled Substances Advisory Commission, and an Advisory Committee on Pain and Symptom Management.

Referred to the Committee on Judiciary

April 12, 2022

Reported without amendment

Without amendment and with the recommendation that the bill pass.

April 28, 2022

Passed in the House 86 to 13 (details)

To create a 14-member “opioid advisory commission” within the Legislative Council, a bipartisan entity that administers the legislative branch of state government. This is related to the "judgment, settlement, or compromise of claims” in legal settlements with certain drug companies (called the "Janssen settlement" and the "National Prescription Opiate Litigation").

Received in the Senate

May 3, 2022

Referred to the Committee on Health Policy and Human Services